ft 05 feb 92 intern compani news merck drug clear key fda hurdl merck world biggest drug compani yesterday given big boost us food drug administr advisori panel decid benefit compani proscar drug treat control benign prostat diseas outweigh risk merck said committe ask vote whether drug clear market howev fda expect give final approv come month potenti market proscar enorm half men 50 suffer prostat enlarg although drug avail treat symptom prostat enlarg drug market inhibit enzym trigger product dht caus condit merck pace pharmaceut industri 1980 new drug introduct analyst view proscar merck next blockbust ms hayley kissel analyst smith barney said probabl merck signific new drug end 1995 believ proscar could gener sale dollar 750m dollar 1bn 1995 wall street anticip favour recommend help merck share climb dollar 4 7 8 dollar 158 7 8 decis came close trade advisori panel said proscar signific side effect benefit drug limit small group patient studi significantli outweigh risk drug proscar side effect includ reduc sexual drive advisori panel conclud problem seriou revers mani case test result consid fda show drug reduc prostat size 20 per cent also reduc level hormon implic prostat enlarg much 70 per cent howev analyst concern efficaci drug test show one third patient achiev target urinari flow rate point drug alreadi market creat symptomat relief proscar merck argu drug deal caus problem retard growth prostrat proscar may capabl halt progress diseas could also use exist symptomat relief drug compani said drug first new class drug call 5 alpha reductos inhibitor deal underli hormon chang caus prostrat enlarg merck appli european licenc last summer